期刊文献+

控制人巨细胞病毒感染的策略 被引量:2

Strategies of control human cytomegalovirus infection
下载PDF
导出
摘要 人巨细胞病毒(HCMV)感染对免疫受损人群危害极大。本文综述了目前控制HCMV感染的策略,其中包括药物控制和免疫控制。阐述了使用药物控制HCMV感染的效果,疫苗在控制HCMV感染及引发疾病方面的作用及通过被动免疫控制HCMV感染的现状与进展。对这些策略的了解对控制HCMV感染具有重要意义。 HCMV infection greatly endanger immunocompromised people.Strategies of control HCMV infection was summarized as follow.Medicament-control and immuno-control were the main means.The effect of medicament-control,how to use vaccine controlling HCMV infection and related disease,and the role of passive immunity in controlling HCMV infection were introduced in detail.Comprehending these strategies is beneficial to controlling HCMV infection.
出处 《生物技术通讯》 CAS 2002年第3期214-217,共4页 Letters in Biotechnology
关键词 人巨细胞病毒感染 药物控制 主动免疫 被动免疫 human cytomegalovirus medicament-control active immunity passive immunity
  • 相关文献

参考文献40

  • 1Ho M. Cytomegalovirus: Biology and infeetions [M].New York:Plenum Press, 1982.309
  • 2Ahlfors K. Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infection[J]. Scan J Infect Dis, 1984,16:129
  • 3King SM. Thearpy and Management of CMV in Patient with HIV Infection [M]. Canada: Minister of Supply and Services Canada
  • 4Munoz A.Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohert study: 1985-1991 [J]. American J Epidemiology, 137(4):423
  • 5Rubin RH, Tolkoff-Rubin NE. Antimicrobial strategies in the care of organ transplant recipients [J]. Antimicrob Agents Chemother, 1993,37:619
  • 6Feinberg JE, Hurwitz S, Cooper D. A randomized, double-blind trial of valaiclovir prophylaxis for cytomegalovinus disease in patients with advanced human immunodeficiency vinus infection [J]. J Infect Dis, 1998, 177:48
  • 7Spector SA.Ganciclovir therapy for Cytomegalovirus infection[M]. New York: Marcel Dekker Inc, 1991
  • 8Tenney DJ, Yamanaka G, Voss SM, et al. Lobulovir ts phosphorylated in hmnan cytomegalovirus-infected and -uninfected cells and inhibits the viral DNA polymerase [J]. Antimicro Agents Chemother, 1997 41,2680-5
  • 9Deeks SG, Collier A, Lalezari J, et al. The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiencyvirus(HIV) therapy, in HIV-infected adults: a randonized, double-blind, placebo-controlled triM[J]. J Infect Dis, 1997,176:1517
  • 10Marshall GS, Plotkin SA. Progress toward developing a cytomegalovirus vaccine[A]. In: Moellering RC, editor. Infection Disease Clinics of North America [J].Philadelphia:WB Saunders Co, 1990.283

同被引文献34

  • 1张化天,张丽辉.美国Syntex新药介绍[J].沈阳医药,1994,9(3):30-34. 被引量:1
  • 2刘鑫荣.更昔洛韦对巨细胞病毒感染的治疗应用[J].国外医药(抗生素分册),1996,17(1):66-67. 被引量:5
  • 3胡增建,蒋华良,杨玉社,陈凯先,嵇汝运.抗病毒药物研究新进展[J].中国药理学通报,1996,12(5):385-388. 被引量:3
  • 4Oon CJ,Chen WN,Lim N,et al.Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ""a"" epitope of the surface antigen are sensitive to ganciclovir[J].Antiviral Res ,1999,41:113
  • 5Tokimasa S,Hara J,Osugi Y,et al.Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation[J].Bone Marrow Transplant,2002,29(7) :595
  • 6Henkin CC,Griener JC,Ten Eick AP.Stability of valganciclovir in extemporaneously compounded liquid formulations[J].Am J Health Syst Pharm,2003,60: 687
  • 7Emery V C,Hassan- Walker AF.Focus on new drugs in development against human cytomegalovirus[J].Drugs,2002,62(13): 1853
  • 8Pat weiskittel.Valganciclovir hydrochloride: a new antiviral agent[J].JNephrolNurs,2003,30(1):93
  • 9Bozkaya H,Yurdaydin C,Bozdayi AM,et al.Oral ganciclovir for treatment of lamivudine-resistant hepatitis B Virus infection: a pilot study[J].Clin Infect Dis,2002,35: 960
  • 10Hadziyannis SJ,Manesis EK,Papakonstantinou A.Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study[J].J Hepatol,1999,31:210

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部